Kellie Watson

Head of Licensing, Corporate Development | Consulate General of Canada (CTA Boston)

Westborough, MA, UNITED STATES

Kellie Watson is an expert in biotechnology, scientific communications, and assisting biotechnology companies.

Biography

Kellie Watson, Ph.D. serves as Head of Licensing, Corporate Development at Laboratory Corporation of America Holdings, an S&P 500 company and a global provider of clinical laboratory and drug development services. Previously, she served as Vice President of Business Development at Epitome Biosystems, Inc. , and Director of Business Development for Pyrosequencing AB, a biotechnology company that developed, manufactured and sold genetic analysis instrumentation and consumable products for the Life Sciences market. Dr. Watson is a Co-founder of Beacon BioPartners, LLC. and served as a Vice President at Feinstein Kean Healthcare (an Ogilvy Public Relations subsidiary), a communications and business consultancy that specialized in scientific communications, and assisting biotechnology companies with corporate strategy to support financing and partnering activities. Dr. Watson was a post doctoral fellow at Harvard University. She holds a Ph.D. from the University of California, Irvine, a M.S. degree from Kansas State University and a B.Sc. Honours degree from Queens University.